As the gap widens between patients on transplant waiting lists and available donor organs, current focus is on improving immunological matching and donor organ quality and reducing cold ischaemia time. However, with approximately 1 in 5 transplanted kidneys failing within the first 5 years, is it time to rethink post-transplantation monitoring?
Join us as we explore emerging markers, such as de novo donor-specific antibodies, donor-derived cell-free DNA, Torque teno virus, urinary exosomes and gene expression profiling; why these markers could signal allograft injury earlier than current methods allow, and why many of these innovative tests are a natural fit for the Histocompatibility and Immunogenetics laboratory.
Thursday, 30th October 2025
13:00 – 13:45 including Q&A session
Hosted by: Jess Brookes, Transplant Technical Sales Specialist
